Welcome to our dedicated page for Alignment Healthcare news (Ticker: ALHC), a resource for investors and traders seeking the latest updates and insights on Alignment Healthcare stock.
Alignment Healthcare, Inc. reports developments tied to its Medicare Advantage business for seniors, including health plan membership, revenue growth, adjusted gross profit, adjusted EBITDA and annual guidance. The company operates under the Alignment Health consumer brand and works with local provider partners to deliver coordinated care through a customized care model, a 24/7 concierge care team and the AVA® technology platform.
Recurring updates include quarterly and full-year results, membership outlooks for HMO and PPO contracts, Medicare Advantage operating trends, investor conference presentations and registered offerings involving common stock. News also follows the company's expansion of health plan offerings and national footprint within senior care.
Alignment Healthcare (NASDAQ: ALHC) announced leadership expansions to support its growth in providing Medicare Advantage services to seniors across the U.S. Dawn Maroney will oversee new market management and development, while Dinesh Kumar, M.D. will lead operations and technology infrastructure. These changes aim to enhance care quality for seniors. Recent appointments to the Board of Directors also aim to facilitate nationwide scaling. CEO John Kao emphasized that investing in leadership is crucial for sustainable growth and improving healthcare delivery for seniors.
Summary not available.
Alignment Healthcare (ALHC) reported its Q4 and full-year 2021 results, highlighting a 26% increase in health plan membership to approximately 86,100 and a 23% rise in total revenue to $298.3 million. The company recorded an adjusted gross profit of $42.7 million, though faced a net loss of $47.8 million. For 2022, Alignment anticipates revenue between $330 million and $335 million, with health plan membership expected to grow to around 93,700 to 93,900. The medical benefits ratio for Q4 was reported at 85.7%, indicating improved efficiency.
Alignment Healthcare (Nasdaq: ALHC) announced its participation in two upcoming investor conferences. CEO John Kao and CFO Thomas Freeman will present at Cowen’s 42nd Annual Health Care Conference on March 8, 2022, at 1:30 p.m. EST, and at Raymond James 43rd Annual Institutional Investor Conference on March 9, 2022, at 11:35 a.m. EST. Both events will focus on the company's tech-enabled Medicare Advantage offerings, which cater to seniors and chronically ill patients, emphasizing customized care solutions.
Alignment Healthcare (Nasdaq: ALHC) is set to announce its Q4 and full-year 2021 financial results on March 3, 2022, after the market closes. A conference call will follow at 5 p.m. E.T. for discussion of these results. The call can be accessed through specific dialing codes for U.S. and international participants and will also be available via a live audio webcast. Alignment Healthcare aims to deliver tailored healthcare solutions, focusing on seniors and the chronically ill, through its Medicare Advantage plans.
Alignment Healthcare, a tech-enabled Medicare Advantage company, reported that its Q4 2021 inpatient utilization was about 5% lower than expected, highlighting the effectiveness of its AVA health platform. The company's health plan membership reached 92,700 as of January 1, 2022, marking a 16% increase from January 2021. Alignment remains focused on innovation, coordinated care, and expanding partnerships with major providers while serving 38 counties across four states and offering over 40 health plans.
Alignment Healthcare, a tech-enabled Medicare Advantage company, announced participation in the 40th Annual J.P. Morgan Healthcare Conference. CEO John Kao and CFO Thomas Freeman will present on January 12, 2022, at 4:30 p.m. E.T. An audio replay will be available on their website.
Alignment Healthcare focuses on consumer-centric healthcare for seniors and chronically ill patients through customized Medicare Advantage plans. The company emphasizes clinical coordination, risk management, and technology facilitation to improve care delivery and reduce costs.
Alignment Healthcare (NASDAQ: ALHC) has appointed Jody Bilney and Yon Yoon Jorden to its Board of Directors, effective January 1, 2022. This decision expands the board from nine to eleven members, enhancing female representation to over one-third. Bilney, a former chief consumer officer at Humana, brings extensive experience in business strategy and transformation, while Jorden has held several senior management roles in healthcare services. The company aims to leverage their expertise to scale operations nationwide and improve care for seniors.
GRAIL, LLC has partnered with Alignment Health Plan to provide Medicare Advantage members in California and North Carolina access to Galleri®, a multi-cancer early detection blood test. Starting January 1, 2022, new and existing members can obtain the test, which detects over 50 cancers, many of which lack standard screenings. The initiative aims to enhance cancer detection among seniors, thereby potentially reducing late-stage diagnoses.
Alignment Healthcare announced the completion of its public offering of 9,200,000 shares of common stock at $21.00 per share. The offering included the full exercise of underwriters' option for an additional 1,200,000 shares. Proceeds will not benefit the company, as shares are sold by existing stockholders. The registration statement was effective as of November 18, 2021. Major financial institutions participated as book-running managers in the offering. This move reflects Alignment Healthcare's ongoing strategy to enhance its Medicare Advantage services without direct financial inflow from the sale.